TCFG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Buy
618
+1
+0.2% +$1.01K 0.21% 116
2025
Q4
$663K Hold
617
0.26% 102
2025
Q3
$471K Sell
617
-213
-26% -$159K 0.18% 143
2025
Q2
$647K Buy
830
+175
+27% +$136K 0.29% 87
2025
Q1
$541K Buy
655
+25
+4% +$20.8K 0.27% 98
2024
Q4
$486K Sell
630
-30
-5% -$24.8K 0.24% 103
2024
Q3
$585K Buy
+660
New +$593K 0.29% 81

Other funds holding LLY

TCFG Wealth Management's LLY Position: Q1 2026 in Review

TCFG Wealth Management increased its Eli Lilly (LLY) stake by 0.16% in Q1 2026, buying an estimated $1.01K and bringing the position to 618 shares worth $568K. The position accounts for 0.21% of the portfolio, ranked #116.

TCFG Wealth Management first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $663K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TCFG Wealth Management held 618 shares of Eli Lilly worth $568K as of Q1 2026.
  • TCFG Wealth Management bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.21% of TCFG Wealth Management's portfolio in Q1 2026, its #116 holding.
  • TCFG Wealth Management first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • TCFG Wealth Management's Eli Lilly position peaked at $663K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TCFG Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.